FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3199611000001102: Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17382701000001119 Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65961701000001110 Stilnoct 10mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Zolpidem false Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Zolpidem tartrate false Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Is a Stilnoct true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Zolpidem tartrate true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is pack of False Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has AMP True Stilnoct 10mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start